Loma Linda University Eye Institute

Loma Linda, California 92354

4 studies enrolling now · 11 studies all time

What they study most

Corneal Scar, Herpes Zoster Ophthalmicus, Infection Prophylaxis, Juvenile Idiopathic Arthritis, Limbal Stem Cell Deficiency, Neurotrophic Keratitis, Neurotrophic Keratopathy, Non Arteritic Anterior Ischemic Optic Neuropathy, Pars Plana Vitrectomy, Retinopathy of Prematurity, Scleral Buckling, Surgical Outcomes

Studies at this site

• Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency — Recruiting now
• A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis — Recruiting now
• Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars — Recruiting now
• Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2 — Recruiting now
• Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects — Completed
• Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next) — Running, not enrolling
• Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis — Completed
• Necessity of Post-operative Eye Drops — Stopped early
• Zoster Eye Disease Study — Completed
• Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) — Stopped early
• Efficacy Study Of Tofacitinib In Pediatric JIA Population — Completed